Related Experiment Videos
Immunohistochemical staining for ferritin in neuroblastomas
R L Carter1, J M Hall, R P Corbett
1Section of Pathology, Royal Marsden Hospital, Sutton, UK.
Histopathology
|May 1, 1991
Summary
Neuroblastoma tumors showed increased ferritin staining after chemotherapy, particularly in partly differentiated cells. This rise in ferritin and hemosiderin accumulation may be linked to blood transfusions in treated children.
Area of Science:
- Pediatric Oncology
- Biochemistry
Background:
- Neuroblastoma is a common childhood cancer often presenting at advanced stages.
- Ferritin, an iron-storage protein, is implicated in various cellular processes, including cancer progression.
Purpose of the Study:
- To investigate the expression of ferritin in neuroblastoma tumors.
- To compare tumor ferritin levels with serum ferritin in pediatric patients.
- To assess changes in ferritin expression following chemotherapy.
Main Methods:
- Immunohistochemical staining for ferritin was performed on neuroblastoma tumor biopsies.
- Samples were analyzed from diagnosis and after chemotherapy.
- Results were correlated with serum ferritin levels and clinical stage.
Main Results:
- Only 7% of diagnostic biopsies showed positive ferritin staining.
- Post-chemotherapy, 38% of neuroblastomas exhibited ferritin positivity.
- No consistent correlation was found between tumor and serum ferritin levels.
- Ferritin staining was more pronounced in partly differentiated cells of treated tumors.
Conclusions:
- Chemotherapy increases ferritin expression in neuroblastomas.
- Accumulation of ferritin and hemosiderin in treated tumors may be influenced by blood transfusions.
- Ferritin expression changes post-chemotherapy may indicate tumor response or cellular alterations.